Australia: ACL makes off-market bid for Healius

Healius, Australia’s second-largest pathology provider and third-largest diagnostic imaging provider, is the target of an off-market takeover bid from the country’s third largest private hospital pathology businesses, Australian Clinical Labs (ACL). The merger would create the largest pathology provider in Australia with approximately A$2.7bn (US$1.81bn) in revenue. ACL has offered 0.74 ACL shares for every…

You must be a HMI Subscriber to view this content.

Subscribe Now »